Maca (Lepidium Meyenii)
Maca is the root of an Andean Brassicaceae; controlled studies show improvements in menopausal symptoms, libido and mood.
We evaluated 36 human studies on Maca (Lepidium meyenii), including 15 randomised controlled trials and 8 meta-analyses or systematic reviews; the controlled studies include 802 participants in total. As of 14 October 2026.
1. What Is Maca (Lepidium Meyenii)? Occurrence, Origin and Forms
Maca is a cruciferous plant (Brassicaceae) cultivated in the highlands of the Andes. Its main use is the thickened root, which is eaten dried as a food. Traditionally, it is regarded in its region of origin as a food and a tonic, mentioned in connection with fertility, energy and well-being during menopause.
Maca thrives at high altitude on poor soils of the Andes and is cultivated there as a crop. Outside that region it is grown as a crop only in a few places.
The root is harvested, dried and processed into powder or flour; for supplements it is additionally heated (gelatinized) or processed into extracts. Human studies mainly use dried root powder, gelatinized powder, and aqueous or alcoholic extracts.
Forms and Preparations Studied
- Dried root powder
- Gelatinized powder (heated material)
- Aqueous extract
- Alcoholic extract
- Root colour types: yellow, red, black
- Maca flour as a food
Not covered on this page:
- Other Lepidium species, such as garden cress (Lepidium sativum)
- Preparations combining maca with other ingredients (mixtures)
- Other root and tuber crops used in a similar way, such as ginseng
2. What Does Maca (Lepidium Meyenii) Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Sexual Function and Libido | mostly improved | moderate | 1 meta-analyses · 5 controlled · 6 other | 189 |
| Menopausal Symptoms | mostly improved | moderate | 1 meta-analyses · 5 controlled · 2 other | 265 |
| Semen Quality and Male Fertility | mostly no difference | moderate | 2 meta-analyses · 3 controlled · 5 other | 139 |
| Mood and Psychological Well-Being | mostly improved | moderate | 0 meta-analyses · 3 controlled · 3 other | 225 |
| Fatigue and Exhaustion | mostly improved | low | 0 meta-analyses · 1 controlled · 2 other | 175 |
| Other investigations | mixed | high | 2 meta-analyses · 14 controlled · 7 other | 668 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Maca (Lepidium Meyenii), Sexual Function and Libido: Human Studies
In men with symptoms of late-onset hypogonadism, gelatinized maca improved erectile function more than placebo 11. In men with mild erectile dysfunction, the IIEF-5 score increased more with a dry extract than with placebo; the effect was small 14. In women with antidepressant-induced sexual dysfunction, the remission rate was higher with maca than with placebo, especially in postmenopausal women 15. In a dose-comparison study, sexual function improved only with the higher dose, not with the lower one 19. A randomized controlled trial in postmenopausal women found an improvement in sexual dysfunction 21. Another randomized controlled trial in healthy men found increased sexual desire 23. The findings are predominantly based on dried root powder and gelatinized powder, the individual studies are small and short, and a meta-analysis on herbal agents for erectile dysfunction provides no clear result specifically for maca 1.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Borrelli et al. 2018 | meta-analysis · 2,080 participants | Herbal dietary supplements, including Lepidium meyenii (n=50); vs. Placebo or other herbal treatments | Erectile function (IIEF-5): unclear (very preliminary positive results) |
| 11 Shin et al. 2023 | randomised controlled · 80 participants | Gelatinized Maca (Lepidium meyenii); 1,000 mg three times daily before food; 12 weeks; vs. Placebo | International Index of Erectile Function (IIEF): improved (p<0.05) |
| 14 Zenico et al. 2009 | randomised controlled · 50 participants | Maca dry extract; 2400 mg; 12 weeks; vs. Placebo | IIEF-5 score: improved (1.6 +/- 1.1 versus 0.5 +/- 0.6, P < 0.001) |
| 15 Dording et al. 2015 | randomised controlled · 45 participants | Maca root (dried powder); 3.0 g/day; 12 weeks; vs. Placebo | ASEX total score ≤ 10 (remission): improved (9.5% for maca versus 4.8% for placebo); MGH-SFQ score ≤ 12 (remission): improved (30.0% for maca versus 20.0% for placebo); MGH-SFQ score ≤ 8 (remission): improved (9.5% for maca versus 5.0% for placebo) |
| 19 Dording et al. 2008 | study · 20 participants | Maca root (L. meyenii); 1.5 g/day or 3.0 g/day; vs. Low dose (1.5 g/day) versus high dose (3.0 g/day) | ASEX score (ITT, 3.0 g/day): improved (from 22.8+/-3.8 to 16.9+/-6.2; z=-2.20, P=0.028); MGH-SFQ score (ITT, 3.0 g/day): improved (from 24.1+/-1.9 to 17.0+/-5.7; z=-2.39, P=0.017); ASEX and MGH-SFQ scores (1.5 g/day): no difference |
| 21 Brooks et al. 2008 | randomised controlled · 14 participants | Maca root powder (Lepidium meyenii); 3.5 g/day; 6 weeks Maca, 6 weeks placebo (crossover, 12 weeks); vs. placebo, randomized double-blind | Greene Climacteric Scale: sexual dysfunction: improved (P < 0.05) |
| 23 Gonzales et al. 2002 | randomised controlled | Maca Gelatinizada; 1,500 mg or 3,000 mg daily; 12 weeks; vs. Placebo | Self-perception of sexual desire: improved (since 8 weeks of treatment) |
| 26 Ross et al. 2024 | case series · 2 participants | Maca-OG™, gelatinized, highly bioavailable powder of specific phenotypes | Total testosterone: improved |
Further studies in this area: 28 32 33 34
Maca (Lepidium Meyenii) and Menopausal Symptoms: Human Studies
For menopausal symptoms, a systematic review and a randomized controlled trial found lower scores on Kupperman and Greene scales; the review rates the evidence as limited 816. Two randomized controlled trials found an improved Kupperman index 1020. Two randomized controlled trials reported a decrease in hot flashes and night sweats 1016, one randomized controlled trial reported an improvement in depressive mood 17 and another reported higher estradiol, FSH and progesterone levels 20. For the remaining laboratory values, one randomized controlled trial found no difference 17. Predominantly gelatinized powder was examined, as well as dried root powder of the maca root; the studies were small and short, and information on the ecotype of the root and on manufacturer funding is mostly missing.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 8 Lee et al. 2011 | systematic review | maca-based intervention (form not reported); vs. placebo | Kupperman Menopausal Index and Greene Climacteric Score: unclear |
| 10 Meissner et al. 2006 | randomised controlled · 168 participants | Pre-gelatinized organic maca (Maca-GO) in capsules; 2 × 500 mg twice daily with meals, total 2 g/day; three (Trial I, n=102) or four (Trial II, n=66) months; vs. Placebo, double-blind, randomized, multi-centre | Kupperman's Index: improved (from 22 to 10); frequency and severity of individual menopausal symptoms (hot flushes, night sweating): improved |
| 16 Meissner et al. 2006 | randomised controlled · 34 participants | Pre-gelatinized organic maca (Maca-GO) capsules; Two 500 mg capsules twice daily with meals, 2 g/day; four months, crossover, outpatient; vs. placebo, double-blind randomized | Menopausal symptoms (Greene's Score, Kupperman Index): improved (alleviated (P<0.001) menopausal symptoms); Hot flushes and night sweating: improved (relieved symptoms of menopausal discomfort, (hot flushes and night sweating in particular)) |
| 17 Stojanovska et al. 2015 | randomised controlled · 29 participants | Maca (Lepidium meyenii); 3.3 g/day; 6 weeks each phase, 12 weeks total; vs. placebo, randomized double-blind cross-over | depression (mood): improved (significant decreases in diastolic blood pressure and depression); estradiol, FSH, TSH, SHBG, glucose, lipid profiles, serum cytokines: no difference (no differences) |
| 20 Meissner et al. 2006 | randomised controlled · 20 participants | Pre-gelatinized organic Maca (Maca-GO), capsules; 2 x 500 mg twice daily, total 2 g/day; 4 months, crossover after 2 months; vs. Placebo capsules, double-blind, randomized | Kupperman Menopausal Index: improved (74%-87%); Estradiol (E2): improved; FSH: improved |
| 21 Brooks et al. 2008 | randomised controlled · 14 participants | Maca root powder (Lepidium meyenii); 3.5 g/day; 6 weeks Maca, 6 weeks placebo (crossover, 12 weeks); vs. placebo, randomized double-blind | Greene Climacteric Scale: psychological symptoms (anxiety, depression): improved (P < 0.05) |
| 28 Ulloa et al. 2024 | review | Maca preparations of varying form and processing | menopausal symptoms: improved |
| 30 Depypere et al. 2014 | review | Lepidium meyenii (Maca) extracts; vs. Placebo (RCTs) | Vasomotor symptoms: improved |
Maca (Lepidium Meyenii), Semen Quality and Male Fertility: Human Studies
On sperm quality and male fertility, several controlled studies and two review articles are available that do not show a uniform picture. A randomized controlled trial reported a higher sperm concentration in men with mild astheno- and/or oligozoospermia taking 2 g of maca daily than with placebo 12. For sperm motility, semen volume and normal sperm morphology, the same study found no difference 12. A small randomized controlled pilot study in healthy men saw only increasing trends compared with placebo for sperm concentration and motility 18. Another randomized controlled trial with yellow maca powder found no difference in sperm concentration in infertile men 13. A systematic review reports better sperm motility in infertile men and better semen quality parameters in healthy men 7, while a meta-analysis shows no difference in sperm concentration and unclear results for semen quality parameters 5. The findings come predominantly from small, short studies in different populations; the forms used range from dried root powder to gelatinized powder to preparations not further specified, and the evidence is inconsistent regarding ecotypes, amount and duration of use.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 5 Lee et al. 2022 | meta-analysis | Maca (Lepidium meyenii), form not reported; vs. Placebo | sperm concentration: no difference (weighted mean difference, 2.22, 95% confidence interval -2.94 to 7.37, p = 0.4); semen quality parameters (sperm concentration, sperm motility): unclear |
| 7 Lee et al. 2016 | systematic review | Maca (Lepidium meyenii), form not specified; vs. Placebo or baseline (3 RCTs, 2 uncontrolled observational studies) | Sperm mobility in infertile men: improved; Several semen quality parameters in healthy men: improved |
| 12 Alcalde et al. 2020 | randomised controlled · 69 participants | Maca (Lepidium meyenii), form not specified; 2 g/day; 12 weeks; vs. Placebo | sperm concentration: improved (15.04 ± 5.61 vs. 10.16 ± 3.59, respectively; p = .011); semen volume: no difference (2.95 ± 0.52 vs. 2.90 ± 0.52; p = .392); sperm motility: no difference (22.34 ± 2.22 vs. 23.05 ± 2.22; p = .462) |
| 13 Melnikovova et al. 2021 | randomised controlled · 50 participants | Yellow maca (Lepidium meyenii Walpers); 16 weeks; vs. Placebo | sperm concentration: no difference (improved the percentage of sperm concentration by 40%, whereas the placebo improved by 76%) |
| 18 Melnikovova et al. 2015 | randomised controlled · 20 participants | milled maca hypocotyl or placebo; 1.75 g/day; 12 weeks; vs. placebo, double-blind randomized | sperm concentration: no difference (rising trends); sperm motility: no difference (rising trends) |
| 26 Ross et al. 2024 | case series · 2 participants | Maca-OG™, gelatinized, highly bioavailable powder of specific phenotypes | Sperm concentration, motility, total sperm count: improved |
| 29 Abarikwu et al. 2020 | review | Lepidium meyenii and other medicinal plants | spermatogenesis-inducing effect: unclear |
| 32 Gonzales et al. 2012 | review | Maca (Lepidium meyenii), form not specified | sperm count and motility: improved |
Further studies in this area: 34 35
Maca (Lepidium Meyenii), Mood and Psychological Well-Being: Human Studies
A randomized controlled trial with aqueous extract of black or red maca found better mood in adults at low and high altitude 9. Another randomized controlled trial with maca dry extract found a greater increase in the score for mental performance in the satisfaction profile SAT-P in men with mild erectile dysfunction than with placebo 14. In contrast, a randomized controlled trial with gelatinized powder (Maca Gelatinizada) found no difference in depression and anxiety in healthy men 23. The evidence is moderate; the findings come from three controlled studies with a total of 225 participants that investigated different forms and ecotypes, and no meta-analysis is available.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 9 Gonzales-Arimborgo et al. 2016 | randomised controlled · 175 participants | spray-dried extracts of black or red maca; 3 g daily; 12 weeks; vs. placebo | mood: improved |
| 14 Zenico et al. 2009 | randomised controlled · 50 participants | Maca dry extract; 2400 mg; 12 weeks; vs. Placebo | SAT-P psychological performance-related score: improved (+9 +/- 6 versus +6 +/- 5, P < 0.05) |
| 23 Gonzales et al. 2002 | randomised controlled | Maca Gelatinizada; 1,500 mg or 3,000 mg daily; 12 weeks; vs. Placebo | Hamilton test for depression: no difference; Hamilton test for anxiety: no difference |
| 26 Ross et al. 2024 | case series · 2 participants | Maca-OG™, gelatinized, highly bioavailable powder of specific phenotypes | Mood: improved |
| 28 Ulloa et al. 2024 | review | Maca preparations of varying form and processing | subjective wellbeing: improved |
| 34 Gonzales et al. 2009 | review | Maca as powder, capsules, pills, flour, liquor, extracts; vs. Placebo in randomized clinical trials | mood: improved; anxiety: improved |
Maca (Lepidium Meyenii), Fatigue and Exhaustion: Human Studies
A randomized controlled trial with 175 adults at low and high altitude found better energy with an aqueous extract of black or red maca compared with placebo 9. A case series reports more energy with gelatinized powder in one of two men with andropause and sperm dysfunction 26. A review article mentions favorable effects on energy and mood 34. The evidence is low, as only one controlled study is available and the remaining observations have no control group. An aqueous extract and gelatinized powder were investigated, but not the raw root as a food; effects with longer use and with other preparations remain open.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 9 Gonzales-Arimborgo et al. 2016 | randomised controlled · 175 participants | spray-dried extracts of black or red maca; 3 g daily; 12 weeks; vs. placebo | energy: improved |
| 26 Ross et al. 2024 | case series · 2 participants | Maca-OG™, gelatinized, highly bioavailable powder of specific phenotypes | Energy: improved |
| 34 Gonzales et al. 2009 | review | Maca as powder, capsules, pills, flour, liquor, extracts; vs. Placebo in randomized clinical trials | energy: improved |
Maca (Lepidium Meyenii): Further Outcomes in Studies
In this area, 14 controlled studies with a total of 668 participants as well as two meta-analyses and two systematic reviews were examined. Several controlled studies found improvements in blood pressure values after dried root powder or gelatinized powder 1720. Several controlled studies also found improved blood lipid values after gelatinized powder 1020. For hormones, a mixed picture emerged: Two controlled studies found higher estradiol and lower FSH values after gelatinized powder 1016, while several controlled studies found no differences in serum hormones 18212223. One controlled study reported a decrease in free testosterone 13. The studies are heterogeneous with regard to the maca form used, the ecotype, and the number of participants, and several investigations include only small samples.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Huerta et al. 2024 | meta-analysis | Maca (Lepidium meyenii Walp.) supplementation; higher doses showed greater effect (dose-response effect); vs. Control groups in randomized controlled studies | Forced swimming test (FST): improved (SMD = 2.26); Rota-rod test (RRT): improved (SMD = 6.26); Grip strength test (GST): improved (SMD = 5.23) |
| 3 Huerta et al. 2024 | meta-analysis | Lepidium meyenii Walp (Maca), including macamides; higher dose produced greater antioxidant effect; vs. control groups (randomized controlled trials) | Reduced glutathione: improved (SMD = 0.89); Glutathione peroxidase: improved (SMD = 0.96); Superoxide dismutase: improved (SMD = 0.68) |
| 4 Morgado et al. 2024 | systematic review | 27 proposed testosterone boosters, including Lepidium meyenii; vs. Placebo | Serum total testosterone: no difference |
| 6 Brunetti et al. 2020 | systematic review | Lepidium meyenii Walp. (maca) as herbal aphrodisiac | Psychiatric and neurological adverse effects |
| 9 Gonzales-Arimborgo et al. 2016 | randomised controlled · 175 participants | spray-dried extracts of black or red maca; 3 g daily; 12 weeks; vs. placebo | health-related quality of life score (HRQL): improved; chronic mountain sickness (CMS) score: improved; hemoglobin in highlanders with abnormally high levels: improved |
| 10 Meissner et al. 2006 | randomised controlled · 168 participants | Pre-gelatinized organic maca (Maca-GO) in capsules; 2 × 500 mg twice daily with meals, total 2 g/day; three (Trial I, n=102) or four (Trial II, n=66) months; vs. Placebo, double-blind, randomized, multi-centre | Estradiol (E2): improved (P<0.001); FSH: improved (P<0.05); HDL: improved (P<0.05) |
| 11 Shin et al. 2023 | randomised controlled · 80 participants | Gelatinized Maca (Lepidium meyenii); 1,000 mg three times daily before food; 12 weeks; vs. Placebo | Aging Males' Symptoms scale (AMS): improved (p<0.05); International Prostate Symptom Score (IPSS): improved (p<0.05); ADAM positive rate: improved (p<0.0001) |
| 13 Melnikovova et al. 2021 | randomised controlled · 50 participants | Yellow maca (Lepidium meyenii Walpers); 16 weeks; vs. Placebo | serum hormone levels: no difference (No statistically significant change in hormone levels); free testosterone: worsened (a decrease in the level of free testosterone) |
Further studies in this area: 14 16 17 18 20 21 22 23 24 25 26 27 28 31 34
4. How Is Maca (Lepidium Meyenii) Dosed? Preparation, Dose and Duration in Studies
The studies predominantly used dried root powder and gelatinized powder, as well as aqueous and alcoholic extracts. Individual investigations examined specific ecotypes such as yellow, red or black maca. The amounts administered can be found in the table.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| spray-dried extracts of black or red maca | 3 g daily | 12 weeks | 9 |
| Pre-gelatinized organic maca (Maca-GO) in capsules | 2 × 500 mg twice daily with meals, total 2 g/day | three (Trial I, n=102) or four (Trial II, n=66) months | 10 |
| Gelatinized Maca (Lepidium meyenii) | 1,000 mg three times daily before food | 12 weeks | 11 |
| Maca (Lepidium meyenii), form not specified | 2 g/day | 12 weeks | 12 |
| Yellow maca (Lepidium meyenii Walpers) | — | 16 weeks | 13 |
| Maca dry extract | 2400 mg | 12 weeks | 14 |
| Maca root (dried powder) | 3.0 g/day | 12 weeks | 15 |
| Pre-gelatinized organic maca (Maca-GO) capsules | Two 500 mg capsules twice daily with meals, 2 g/day | four months, crossover, outpatient | 16 |
| Maca (Lepidium meyenii) | 3.3 g/day | 6 weeks each phase, 12 weeks total | 17 |
| milled maca hypocotyl or placebo | 1.75 g/day | 12 weeks | 18 |
| Pre-gelatinized organic Maca (Maca-GO), capsules | 2 x 500 mg twice daily, total 2 g/day | 4 months, crossover after 2 months | 20 |
| Maca root powder (Lepidium meyenii) | 3.5 g/day | 6 weeks Maca, 6 weeks placebo (crossover, 12 weeks) | 21 |
| Maca Gelatinizada | 1500 mg or 3000 mg per day | 12 weeks | 22 |
| Maca Gelatinizada | 1,500 mg or 3,000 mg daily | 12 weeks | 23 |
| Lepidium meyenii extract (form unspecified) | 2.25 g twice daily | 12 weeks | 24 |
5. Is Maca (Lepidium Meyenii) Safe? Side Effects in Studies
In the studies, maca was predominantly well tolerated; one placebo-controlled study reported no serious side effects 91519. A review reports rare side effects and good tolerability at therapeutic dose, but points to risks with overdose or self-medication 628. A case report mentions an elevated blood lead concentration 27.
| Study | Reported side effects |
|---|---|
| 1 Borrelli et al. 2018 | Recorded in 19 of 24 trials, no significant differences vs placebo |
| 6 Brunetti et al. 2020 | Psychiatric and neurological adverse effects; mostly safe at therapeutic doses, risks with overdose or self-medication |
| 8 Lee et al. 2011 | safety not proven |
| 9 Gonzales-Arimborgo et al. 2016 | good acceptability, no serious adverse effects |
| 11 Shin et al. 2023 | Maca called safe, no figures reported |
| 15 Dording et al. 2015 | Maca was well tolerated |
| 19 Dording et al. 2008 | Maca was well tolerated |
| 20 Meissner et al. 2006 | Rat toxicity safe at 7.5 mg/kg body weight |
| 27 Johnson-Arbor et al. 2018 | whole blood lead concentration 44 µg/dL |
| 28 Ulloa et al. 2024 | generally safe, rare adverse effects, good tolerance |
6. What Remains Open: Limits of the Evidence
- Most studies are small and short; information on ecotype and manufacturer funding is often missing.
- The forms and preparations used differ greatly, which makes comparison difficult.
- Regarding semen quality, the results are inconsistent and the evidence is heterogeneous.
- Long-term effects and effects with longer use are hardly studied.
- Combination products with other ingredients do not allow any statement about maca alone.
7. Bottom Line: What Is Established About Maca (Lepidium Meyenii)
Maca is the thickened root of the Andean Brassicaceae Lepidium meyenii, which has been studied dried as a food and in various preparations. Controlled human studies show improvements in menopausal symptoms, sexual function and libido, as well as in mood and energy. The strength of evidence is moderate for menopausal symptoms, sexual function and mood, and low for fatigue. For semen quality, the picture is inconsistent. The studies are predominantly small and short, and the forms, ecotypes and amounts used vary greatly.
Frequently Asked Questions
How well has Maca (Lepidium meyenii) been studied in humans?
We evaluated 36 human studies on Maca (Lepidium meyenii), including 15 randomised controlled trials and 8 meta-analyses or systematic reviews; the controlled studies include 802 participants in total. As of 14 October 2026.
Does Maca (Lepidium meyenii) help with sexual Function and Libido? What the studies show
Does Maca (Lepidium meyenii) help with menopausal Symptoms? What the studies show
Does Maca (Lepidium meyenii) help with semen Quality and Male Fertility? What the studies show
Does Maca (Lepidium meyenii) help with mood and Psychological Well-Being? What the studies show
Does Maca (Lepidium meyenii) help with fatigue and Exhaustion? What the studies show
Which forms of maca were examined in the studies?
Primarily dried root powder and gelatinized powder were examined, as well as aqueous and alcoholic extracts. Individual studies examined specific ecotypes such as yellow, red or black maca. The amounts administered can be found in the table.
Do studies in humans show an effect on menopausal symptoms?
How does maca affect sexual function?
Two controlled studies found a greater improvement in erectile function in men with maca than with placebo 1114. In women with antidepressant-induced sexual dysfunction, the remission rate was higher with maca, especially after menopause 15. A study in postmenopausal women found an improvement in sexual dysfunction 21. Another study in healthy men found increased sexual desire 23.
Are there side effects or risks?
In the studies, maca was predominantly well tolerated; one placebo-controlled study reported no serious side effects 91519. A review reports rare side effects and good tolerability at therapeutic dose, but points to risks with overdose or self-medication 628. A case report mentions an elevated blood lead concentration 27.
What should be considered with combination products?
Sources
- 1Borrelli F, Colalto C, Delfino DV, Iriti M, Izzo AA · 2018
- 2Huerta Ojeda Á, Rodríguez Rojas J, Cancino-López J, Barahona-Fuentes G, Pavez L, Yeomans-Cabrera MM et al. · 2024
- 3Huerta Ojeda Á, Rodríguez Rojas J, Cuevas Guíñez J, Ciriza Velásquez S, Cancino-López J, Barahona-Fuentes G et al. · 2024
- 4Morgado A, Tsampoukas G, Sokolakis I, Schoentgen N, Urkmez A, Sarikaya S · 2024
- 5Lee HW, Lee MS, Qu F, Lee JW, Kim E · 2022
- 6Brunetti P, Lo Faro AF, Tini A, Busardò FP, Carlier J · 2020
- 7Lee MS, Lee HW, You S, Ha KT · 2016
- 8Lee MS, Shin BC, Yang EJ, Lim HJ, Ernst E · 2011
- 9Gonzales-Arimborgo C, Yupanqui I, Montero E, Alarcón-Yaquetto DE, Zevallos-Concha A, Caballero L et al. · 2016
- 10Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical StudyMeissner HO, Mscisz A, Reich-Bilinska H, Kapczynski W, Mrozikiewicz P, Bobkiewicz-Kozlowska T et al. · 2006
- 11Shin D, Jeon SH, Piao J, Park HJ, Tian WJ, Moon DG et al. · 2023
- 12Alcalde AM, Rabasa J · 2020
- 13Melnikovova I, Russo D, Fait T, Kolarova M, Tauchen J, Kushniruk N et al. · 2021
- 14Zenico T, Cicero AF, Valmorri L, Mercuriali M, Bercovich E · 2009
- 15Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB et al. · 2015
- 16Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient studyMeissner HO, Mscisz A, Reich-Bilinska H, Mrozikiewicz P, Bobkiewicz-Kozlowska T, Kedzia B et al. · 2006
- 17Stojanovska L, Law C, Lai B, Chung T, Nelson K, Day S et al. · 2015
- 18Melnikovova I, Fait T, Kolarova M, Fernandez EC, Milella L · 2015
- 19Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M et al. · 2008
- 20Therapeutic Effects of Pre-Gelatinized Maca (Lepidium Peruvianum Chacon) used as a Non-Hormonal Alternative to HRT in Perimenopausal Women - Clinical Pilot StudyMeissner HO, Reich-Bilinska H, Mscisz A, Kedzia B · 2006
- 21Brooks NA, Wilcox G, Walker KZ, Ashton JF, Cox MB, Stojanovska L · 2008
- 22Gonzales GF, Córdova A, Vega K, Chung A, Villena A, Góñez C · 2003
- 23Gonzales GF, Córdova A, Vega K, Chung A, Villena A, Góñez C et al. · 2002
- 24Weng PW, Chung YC, Lin TC, Hsu PC, Yang CT, Lin S et al. · 2025
- 25Kang S, Ahn BO, Park MH, Lim ST, Lee E · 2023
- 26
- 27Johnson-Arbor K, Vo K, Wong F, Gajek R · 2018
- 28Ulloa Del Carpio N, Alvarado-Corella D, Quiñones-Laveriano DM, Araya-Sibaja A, Vega-Baudrit J, Monagas-Juan M et al. · 2024
- 29Abarikwu SO, Onuah CL, Singh SK · 2020
- 30Depypere HT, Comhaire FH · 2014
- 31Zeng Y, Yang J, Du J, Pu X, Yang X, Yang S et al. · 2014
- 32
- 33Mazaro-Costa R, Andersen ML, Hachul H, Tufik S · 2010
- 34Gonzales GF, Gonzales C, Gonzales-Castañeda C · 2009
- 35Comhaire FH, Mahmoud A · 2003
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.